Showing articles associated with Shisong Jiang

Dr Shisong Jiang is an Oxford University research group leader in the Department of Oncology, and the CTO of Oxford Vacmedix, which has developed a technique to grow overlapping peptides in bacteria, to use for cellular immunity vaccines.

What is your main area(s) of interest/expertise?

I am an immunologist specialised in viral  infections and tumours. My research area includes antigen presentation and vaccine development.

What are you working on right now?

We have developed a new vaccine technology – recombinant overlapping peptides. I hope this technology would be useful for developing  SARS-CoV-2 vaccines.

We are also developing a T cell-based diagnostic kit for the assessment of cellular immunity of SARS-CoV-2 infected patients.
Lastly, we are trying to develop a cartridge-like medical device which can absorb toxic materials in the SARS-CoV-2 patients with fatal cytokine storms.

Why is Oxford a good place to work in this field of research?

People and network; state-of-art facilities; supportive environment.

Find out more about Shisong

Shisong Jiang
No articles have been associated to Shisong Jiang.